{"id":162496,"date":"2022-06-09T01:55:06","date_gmt":"2022-06-09T05:55:06","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/u-s-fda-approves-foundation-medicines-foundationonecdx-as-a-companion-diagnostic-for-roches-rozlytrek-entrectinib\/"},"modified":"2024-08-18T11:44:58","modified_gmt":"2024-08-18T15:44:58","slug":"u-s-fda-approves-foundation-medicines-foundationonecdx-as-a-companion-diagnostic-for-roches-rozlytrek-entrectinib","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/u-s-fda-approves-foundation-medicines-foundationonecdx-as-a-companion-diagnostic-for-roches-rozlytrek-entrectinib.php","title":{"rendered":"U.S. FDA approves Foundation Medicine\u2019s FoundationOne\u00aeCDx as a companion diagnostic for Roche\u2019s Rozlytrek\u00ae (entrectinib)"},"content":{"rendered":"<p><![CDATA[Basel, 9 June 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the United States Food and Drug Administration (U.S. FDA) has approved Foundation Medicine\u2019s FoundationOne\u00aeCDx as a companion diagnostic (CDx) for Roche\u2019s Rozlytrek\u00ae (entrectinib). FoundationOne CDx is a comprehensive genomic profiling (CGP) pan-tumour tissue biopsy test that assesses an individual\u2019s cancer to identify the unique molecular \u2018fingerprint\u2019 of the tumour. It is the first and only U.S. FDA-approved CDx to identify patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC), or patients with NTRK fusion-positive cancers, for whom treatment with Rozlytrek may be appropriate.]]><\/p>\n<p>Follow this link:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/09\/2459301\/0\/en\/U-S-FDA-approves-Foundation-Medicine-s-FoundationOne-CDx-as-a-companion-diagnostic-for-Roche-s-Rozlytrek-entrectinib.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"U.S. FDA approves Foundation Medicine\u2019s FoundationOne\u00aeCDx as a companion diagnostic for Roche\u2019s Rozlytrek\u00ae (entrectinib)\">U.S. FDA approves Foundation Medicine\u2019s FoundationOne\u00aeCDx as a companion diagnostic for Roche\u2019s Rozlytrek\u00ae (entrectinib)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Follow this link: U.S. FDA approves Foundation Medicine\u2019s FoundationOne\u00aeCDx as a companion diagnostic for Roche\u2019s Rozlytrek\u00ae (entrectinib) <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/u-s-fda-approves-foundation-medicines-foundationonecdx-as-a-companion-diagnostic-for-roches-rozlytrek-entrectinib.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162496","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162496"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162496"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162496\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162496"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162496"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162496"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}